Introduction: The rate of latent tuberculosis infections (LTBIs) in health care workers (HCWs) is higher than that in non-HCWs. We studied to investigate the prevalence and risk factors of LTBIs and the acceptance rate for treatment of LTBI among HCWs in South Korea, a country with an intermediate tuberculosis (TB) burden. Methodology: LTBI screening was conducted for HCWs at a tertiary and a secondary hospital from April 2017 to August 2017. This was a retrospective study included all HCWs who underwent LTBI examination. HCWs were classified by the degree of risk into four groups, based on two factors: possibility of exposure to TB, and impact on patients at the time of TB onset in the HCWs. The interferon-gamma release assay was used for the diagnosis of LTBI. Results: A total of 1326 HCWs were included; they comprised 801 HCWs from a tertiary hospital and 525 from a secondary hospital. A total of 235 (17.7%) HCWs were diagnosed with LTBIs. According to risk classification, there was no significant difference (P = 0.24). In multivariate analysis, age was the only independent risk factor (P < 0.001). The acceptance rate for LTBI treatment was 60.43%, and there were no associated factors in multivariate analysis. Conclusions: HCWs did not show any significant difference in the rate of LTBI by the degree of risk, and age was the independent risk factor. LTBI screening should be conducted for all HCWs regardless of risk classification.
general population [7] [8] [9] . Furthermore, when HCWs develop active TB, they may transmit the infection to their patients, including immunocompromised individuals [10] . The Centers for Disease Control and Prevention (CDC) published guidelines for preventing the spread of Mycobacterium tuberculosis (MTB) in healthcare facilities and recommended TB screening programs for all HCWs, with the provision of treatment when LTBI is diagnosed [11] [12] . Although the tuberculin skin test (TST) has been widely used for the diagnosis of LTBI, there is a limitation in that the TST may detect cross reactions with nontuberculous mycobacterial strains or with M. bovis vaccine strains, and the probability of false-positive results is high. The CDC recommends interferongamma release assay (IGRA) as a better alternative to TST for LTBI detection [13] [14] . To address the issue of LTBI screening in the HCW population in Korea, the Korean Manual for TB Management in Medical institutions was updated in 2016 [15] . Based on these guidelines, we studied the prevalence and risk factors for LTBI and the acceptance rate for LTBI treatment among HCWs in a tertiary and a secondary hospital.
Methodology

Study Population
This was a retrospective review of medical records of all HCWs being tested for LTBI. LTBI screening in HCWs was conducted from April 2017 to August 2017 at a tertiary hospital (hospital A) with 969 beds and a secondary hospital (hospital B) with 450 beds in South Korea based on the guideline. The HCWs included all employees (e.g., physicians, nurses, nursing assistants, paramedics, clerical staff, laboratory workers, food service workers) working in the hospital. (Table 1) .
We excluded HCWs who either completed treatment of TB or LTBI in the past or were currently being treated. But there was no baseline data of LTBI for all staff. We obtained information regarding working healthcare facility, age, sex, number of years of service, department of work (doctors, nurses, nursing assiatants, lab workers, and others including clerks) for all participants via analyzing the medical records. To rule out active TB while screening for LTBI, all participants underwent a chest X-ray examination.
LTBI Screening
LTBI testing was performed with the IGRA test using the QuantiFERON ® -TB Gold in-Tube blood test (QFT-GIT; Cellestis Ltd., Carnegie, VIC, Australia).
The cost of the examination for LTBI was reimbursed as per national policy. The QFT-GIT assay was performed according to the manufacturer's instructions.
Briefly, whole blood is drawn into 3 evacuated blood collection tubes: one containing heparin alone (negative control), one containing T cell mitogen (positive The QFT-GIT test result is considered positive if the IFN-γ response level is at least 0.35 IU/ml.
LTBI Treatment and Monitoring during Treatment
HCWs 
Statistical Analysis
Comparisons between groups were made using the x 2 test for categorical variables and the Student's t-test for continuous variables. Independent variables were analyzed using the logistic regression analysis, and a P-value of <0.05 was considered statistically significant. All statistical analyses were performed using SPSS version 23.0 (IBM Corp., Armonk, NY, USA).
Ethics Statement
The study was approved by the Institutional Review Board of each participating institution. 
Results
Characteristics of Study Subjects
Risk Factors for LTBI
The risk factors for LTBIs are followed by was the LTBI rate (P < 0.001). Of those with more than 30 years of work in the hospitals, 32 (49.2%) were positive, with the LTBI rate increasing with the number of years of medical service (P < 0.001). The rate of LTBI was higher in males, with 85 cases (24.6%) (P < 0.001). According to the occupational classification, the LTBI rate was significantly higher in lab workers, with 15 cases (27.3%), compared with doctors and nurses (P < 0.001). According to the classification by the degree of risk, there were no significant differences (P = 0.24). In multivariate analysis, only age was independently associated with increased risk for LTBI (P < 0.001).
Treatment of LTBI
Of the 235 HCWs diagnosed with LTBI, 142 (60.4%) started treatment for LTBI.
The determinants associated with acceptance rate for LTBI treatment are shown in Table 4 . The acceptance rate of HCWs at hospital B was 70.9% (61/86), higher than that at hospital A (54.4%, 81/149) (P = 0.01). In terms of age, the acceptance rate of the 20-29 years group was the highest (P < 0.001). The acceptance rate was 66.0% (99/150) in females and 50.6% (43/85) in males (P = 0.02). In terms of years of work in the hospitals, the acceptance rate was the highest in those with less than 11 years of work, at 70.6% (P = 0.02). In terms of the classification according to the degree of risk, the acceptance rate was the highest in group 1 with 68.6% (P = 0.04). In multivariate analysis, there were no independently associated factors.
Of the 142 HCWs who started LTBI treatment, 125 (88.7%) chose INH/RIF, 9 (6.4%) chose RIF and 7 (5%) chose INH. Overall, 9 of 142 (6.3%) HCWs who started treatment with INH/RIF interrupted the treatment due to adverse effects.
Four HCWs interrupted it with hepatotoxicity, 3 HCWs with dizziness, and 2
HCWs with skin rash. HCWs diagnosed as LTBI have been screened annually with chest X-rays to confirm whether LTBI transit to active tuberculosis.
Discussion
In this study, we identified the prevalence and risk factors of LTBI among HCWs in South Korea, a country with an intermediate TB burden, and investigated the treatment acceptance rate of HCWs with LTBI. The proportion of HCWs diagnosed with LTBI was 17.7%, consistent with the prevalence reported by several studies on LTBI among HCWs in South Korea [16] . According to research in South Korea published in 2010, the prevalence of LTBI in HCWs in a university hospital was 23.2%, as measured by QFT-GIT [17] . The Korean government began to provide systematic LTBI diagnosis for about 1.2 million individuals in high risk groups, including HCWs, social welfare facility workers, tional classification, the rate of LTBI in lab workers was highest. In several Korean studies carried out before, laboratory workers were found to be vulnerable to TB infection through exposure to contagious specimens from patients [19] .
Increased age was the only significant risk factor identified in this study. Many other studies also reported increased age to be a factor influencing the increase in LTBI [20] [21] [22] . In the LTBI screening conducted by the government in 2017 mentioned above, the LTBI rate similarly increased with age. Though
HCWs were classified into four categories by the degree of risk, they did not show any significant difference in the rate of LTBI.
In this study, 60.43% of HCWs diagnosed with LTBI began to receive treatment, and 93.7% completed the treatment. In terms of age, the treatment acceptance rate was highest in the youngest age group. The acceptance rate of LTBI treatment was higher in HCWs at the secondary hospital, and in females. The shorter the duration of working life, the higher the treatment acceptance rate.
Moreover, in terms of risk classification, the acceptance rate of the HCWs of group 1 was the highest. Multivariate analysis revealed no independently associated factors. Considering that treatment for LTBI was not obligatory, the perception by HCWs of LTBI may influence treatment decisions. In a ten-year study conducted in a medical center in the US on HCW acceptance rates for LTBI treatment, the overall acceptance rate was 39%, ranging from 31% to 62% [23] . According to the results from other two tertiary hospitals in Korea based on the Korean Manual for TB Management in Medical institutions updated in 2016, the positive rates of LTBI were 18.8% and 20.8% respectively, similar to the result of this study. The acceptance rate for treatment was higher among women, in the younger age group, and in group 1 and 2 among four groups classified by the degree of risk like our study [24] [25]. Our study had several limitations.
First, this was a retrospective review and there is lack of information about the reasons for declining treatment for LTBI. Second, not all HCWs participated in the study, that would affect the final outcome. Additionally, there was no baseline data of LTBI for all HCWs, and it was difficult to confirm whether latent TB was infected by patients.
Conclusion
In conclusion, for HCWs with a high proportion of TB infection, LTBI tests should be recommended. According to risk classification among HCWs, they did not show any significant difference. Only age was independent risk factor for LTBI. As a result, it is necessary to conduct screening of all HCWs, regardless of risk classification. There is a need for additional studies to be performed taking into consideration both the side effects and the effects of the treatment of LTBI in HCWs. It is necessary to investigate the need for treatment of LTBI by the risk classification among HCWs, considering the impact on patients in hospitals at the time of TB onset in the HCWs. Through policies based on this, we will be able to contribute to reducing TB infection in HCWs over the long term and lo-Journal of Tuberculosis Research wering the burden of TB throughout the country.
